BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38400657)

  • 1. Generation of human antibodies targeting human platelet antigen (HPA)-1a.
    Oosterhoff JJ; Linty F; Visser R; de Vos T; Hofstede-van Egmond S; van de Weerd M; Porcelijn L; de Haas M; van der Schoot E; Vidarsson G
    Transfusion; 2024 May; 64(5):893-905. PubMed ID: 38400657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia.
    de Vos TW; Porcelijn L; Hofstede-van Egmond S; Pajkrt E; Oepkes D; Lopriore E; van der Schoot CE; Winkelhorst D; de Haas M
    Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
    Kjeldsen-Kragh J; Bengtsson J
    Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a human platelet antigen-1a-specific monoclonal antibody derived from a B cell from a woman alloimmunized in pregnancy.
    Eksteen M; Tiller H; Averina M; Heide G; Kjaer M; Ghevaert C; Michaelsen TE; Ihle Ø; Husebekk A; Skogen B; Stuge TB
    J Immunol; 2015 Jun; 194(12):5751-60. PubMed ID: 25972474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Anti-HPA-1a Standard Antibodies React with the β3 Integrin Subunit but not with αIIbβ3 and αvβ3 Complexes.
    Bayat B; Traum A; Berghöfer H; Werth S; Zhu J; Bein G; Sachs UJ; Santoso S
    Thromb Haemost; 2019 Nov; 119(11):1807-1815. PubMed ID: 31587244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic and structural analysis of eight novel domain-deletion beta3 integrin peptides designed for detection of HPA-1 antibodies.
    Stafford P; Ghevaert C; Campbell K; Proulx C; Smith G; Williamson LM; Ranasinghe E; Watkins NA; Huntington JA; Ouwehand WH
    J Thromb Haemost; 2008 Feb; 6(2):366-75. PubMed ID: 18045240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
    Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
    Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.
    Yougbaré I; Lang S; Yang H; Chen P; Zhao X; Tai WS; Zdravic D; Vadasz B; Li C; Piran S; Marshall A; Zhu G; Tiller H; Killie MK; Boyd S; Leong-Poi H; Wen XY; Skogen B; Adamson SL; Freedman J; Ni H
    J Clin Invest; 2015 Apr; 125(4):1545-56. PubMed ID: 25774504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HPA-1a alloantibody-mediated platelet destruction by a deglycosylated anti-HPA-1a monoclonal antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia.
    Bakchoul T; Greinacher A; Sachs UJ; Krautwurst A; Renz H; Harb H; Bein G; Newman PJ; Santoso S
    Blood; 2013 Jul; 122(3):321-7. PubMed ID: 23645838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology.
    Socher I; Andrei-Selmer C; Bein G; Kroll H; Santoso S
    Transfusion; 2009 May; 49(5):943-52. PubMed ID: 19175553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An HPA-1a-positive platelet-depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-center, phase 1/2 proof-of-concept study.
    Geisen C; Kjaer M; Fleck E; Skogen B; Armstrong R; Behrens F; Bhagwagar Z; Braeuninger S; Mortberg A; Olsen KJ; Gastón Schäfer SM; Walter C; Seifried E; Wikman A; Kjeldsen-Kragh J; Koehm M
    J Thromb Haemost; 2023 Apr; 21(4):838-849. PubMed ID: 36696185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of human platelet antigen-1a alloantibodies in cases of fetomaternal alloimmune thrombocytopenia using recombinant β3 integrin fragments coupled to fluorescently labeled beads.
    Chong W; Metcalfe P; Mushens R; Lucas G; Ouwehand WH; Navarrete CV
    Transfusion; 2011 Jun; 51(6):1261-70. PubMed ID: 21166681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia.
    Salomon O; Rosenberg N
    Br J Haematol; 2013 Aug; 162(3):304-12. PubMed ID: 23672281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.
    Delbos F; Bertrand G; Croisille L; Ansart-Pirenne H; Bierling P; Kaplan C
    Transfusion; 2016 Jan; 56(1):59-66; quiz 58. PubMed ID: 26469867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic administration of HPA-1a-specific antibodies prevents fetal/neonatal alloimmune thrombocytopenia in mice.
    Zhi H; Sheridan D; Newman DK; Newman PJ
    Blood; 2022 Nov; 140(20):2146-2153. PubMed ID: 35881848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three novel beta3 domain-deletion peptides for the sensitive and specific detection of HPA-4 and six low frequency beta3-HPA antibodies.
    Stafford P; Garner SF; Huiskes E; Kaplan C; Kekomaki R; Santoso S; Tsuno NH; Watkins NA; Ouwehand WH
    J Thromb Haemost; 2008 Feb; 6(2):376-83. PubMed ID: 18031296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel assay for the detection of anti-human platelet antigen antibodies (HPA-1a) based on peptide aptamer technology.
    Thibaut J; Mérieux Y; Rigal D; Gillet G
    Haematologica; 2012 May; 97(5):696-704. PubMed ID: 22133781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding to the complexity of fetal and neonatal alloimmune thrombocytopenia: Reduced fibrinogen binding in the presence of anti-HPA-1a antibody and hypo-responsive neonatal platelets.
    Refsum E; Meinke S; Gryfelt G; Wikman A; Höglund P
    Thromb Res; 2018 Feb; 162():69-76. PubMed ID: 29306729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia.
    Kjær M; Geisen C; Akkök ÇA; Wikman A; Sachs U; Bussel JB; Nielsen K; Walles K; Curtis BR; Vidarsson G; Järås K; Skogen B
    Transfus Apher Sci; 2020 Feb; 59(1):102712. PubMed ID: 31948915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural localization of glycoprotein IIIa (GPIIIa, beta 3 integrin) on placental syncytiotrophoblast microvilli: implications for platelet alloimmunization during pregnancy.
    Kumpel BM; Sibley K; Jackson DJ; White G; Soothill PW
    Transfusion; 2008 Oct; 48(10):2077-86. PubMed ID: 18673340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.